Rudnik-Schöneborn S, Röhrig D, Morgan G, Wirth B, Zerres K
Institute for Human Genetics of Bonn University, Germany.
Am J Med Genet. 1994 May 15;51(1):70-6. doi: 10.1002/ajmg.1320510115.
We analysed the clinical picture of 101 sibs (43 sib pairs, 5 triplets) with autosomal recessive proximal spinal muscular atrophy (SMA). Linkage data of 20 sibships, which were available for analysis, were in agreement with chromosome 5q linkage. The patients were classified according to the motor development into SMA I (never sat), SMA II (sitting without support), and SMA III (walking without aids). Three sibs with adult onset (> 30 years = SMA IV) were discussed as a separate entity. Age-of-onset of the 101 patients showed a wide spectrum (prenatal to 47 years). Among sib pairs with SMA I and SMA II the ages-of-onset appeared to be very similar except of one atypically discordant sib pair. With regard to SMA III, 3 out of 13 sibships (23%) showed a marked variation in age-of-onset ranging from 5-15 years within a family. Concerning acquired motor development (ability to sit and walk), 7 sibships (15%) belonged to different SMA types. Ages of death in 29 sib pairs in whom at least one sib had died before the age of 20 years were strikingly discordant. Neither the degree of disability nor the respiratory deficits are reliable predictors of life expectancy. Although a predominance of males can be observed, no significant effect of gender has been established in familial cases. The existence of multiple allelism seems to be the most suitable explanation for the high interfamilial variability considering the clinical concordance in most affected sib pairs.
我们分析了101例患有常染色体隐性近端脊髓性肌萎缩症(SMA)的同胞(43对同胞,5组三胞胎)的临床表现。可用于分析的20个同胞关系的连锁数据与5号染色体连锁一致。根据运动发育情况,将患者分为SMA I型(从未坐立)、SMA II型(无需支撑可坐立)和SMA III型(无需辅助可行走)。3例成年发病(>30岁=SMA IV型)的同胞作为一个单独的类型进行讨论。101例患者的发病年龄范围很广(从产前到47岁)。在SMA I型和SMA II型的同胞对中,除了一对非典型不一致的同胞对外,发病年龄似乎非常相似。关于SMA III型,13个同胞关系中有3个(23%)在一个家族内发病年龄有显著差异,范围从5岁到15岁。关于后天运动发育(坐立和行走能力),7个同胞关系(15%)属于不同的SMA类型。在29对同胞中,至少有一个同胞在20岁前死亡,其死亡年龄差异显著。残疾程度和呼吸功能障碍都不是预期寿命的可靠预测指标。虽然可以观察到男性占主导,但在家族性病例中尚未确定性别有显著影响。考虑到大多数受影响同胞对的临床一致性,多等位基因的存在似乎是家族间高变异性最合适的解释。